Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 8/20 | 0.33 |
| ▸ | JAK1 | P23458 | 8/20 | 0.33 |
| ▸ | TYK2 | P29597 | 4/20 | 0.32 |
| ▸ | JAK3 | P52333 | 4/20 | 0.32 |
| ▸ | HTR6 | P50406 | 5/20 | 0.32 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.30 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2274417 | 0.85 | JAK1 (0.45) | JAK2JAK1TYK2JAK3PIK3C3 | |
| SCHEMBL2274591 | 0.84 | JAK1 (0.40) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL2225081 | 0.83 | JAK2 (0.34) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2276856 | 0.82 | JAK1 (0.41) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL2224964 | 0.82 | JAK1 (0.46) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL2276537 | 0.80 | JAK1 (0.35) | JAK2JAK1TYK2JAK3HTR6 | |
| SCHEMBL2274375 | 0.78 | JAK1 (0.35) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL14644766 | 0.77 | JAK1 (0.43) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL14603640 | 0.77 | JAK1 (0.43) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL14603785 | 0.77 | JAK1 (0.43) | JAK2JAK1TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |